A Study of Alpharadin® With Docetaxel in Patients With Bone Metastasis From Castration-Resistant Prostate Cancer (CRPC)

This study is currently recruiting participants.
Verified January 2014 by Algeta ASA
Sponsor:
Collaborator:
Bayer
Information provided by (Responsible Party):
Algeta ASA
ClinicalTrials.gov Identifier:
NCT01106352
First received: April 16, 2010
Last updated: January 24, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2014
  Estimated Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)